AnPac Bio-Medical rises on U.S. patent for cancer detection device

Fresh2

11/05/2020 17:52

** Shares of China-based cancer test maker  ANPC.O  rise
11.5% to $8.38
    ** Co receives new U.S. patent for a novel medical device
for cancer detection utilizing integrated circuit technology
 urn:newsml:reuters.com:*:nGNX1znnHH
    ** Co has two certified clinical laboratories in China and
one clinical laboratory in U.S. where it performs a suite of
cancer screening and detection tests
    ** More than 23,276 shares traded, 12.9 times its 25-day
moving avg
    ** Including session's gain, stock down ~25.5% since Jan 30
IPO

 (Reporting by Mrinalika Roy in Bengaluru)
 ((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 8325;))